DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

Search

Enovis Corp

Abrir

SetorSetor Industrial

35.13 3.02

Visão Geral

Variação de preço das ações

24h

Atual

Mín

34.05

Máximo

35.37

Indicadores-chave

By Trading Economics

Rendimento

-672M

-703M

Vendas

56M

561M

EPS

0.98

Margem de lucro

-125.353

Funcionários

7,367

EBITDA

-602M

-590M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+78.56% upside

Dividendos

By Dow Jones

Próximos Ganhos

8 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-782M

1.8B

Abertura anterior

32.11

Fecho anterior

35.13

Enovis Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de jan. de 2025, 23:28 UTC

Grandes Movimentos do Mercado

Maplebear Up on S&P MidCap 400 Inclusion

Comparação entre Pares

Variação de preço

Enovis Corp Previsão

Preço-alvo

By TipRanks

78.56% parte superior

Previsão para 12 meses

Média 62.71 USD  78.56%

Máximo 75 USD

Mínimo 46 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Enovis Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

7

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.